| scholarly article | Q13442814 |
| P2093 | author name string | Konstantinos Drosatos | |
| Ira J Goldberg | |||
| Vassilis I Zannis | |||
| Dimitrios Iliopoulos | |||
| Yaeko Hiyama | |||
| P2860 | cites work | Identification of Drosophila MicroRNA targets | Q21146437 |
| Role of LXRs in control of lipogenesis | Q24290548 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. | Q24542505 | ||
| Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter | Q24550969 | ||
| Identification of mammalian microRNA host genes and transcription units | Q24562298 | ||
| Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta | Q24598068 | ||
| The microRNAs of Caenorhabditis elegans | Q24672515 | ||
| MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies | Q24681266 | ||
| Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways | Q24683796 | ||
| Prediction of mammalian microRNA targets | Q27860498 | ||
| Argonaute2 is the catalytic engine of mammalian RNAi | Q27860545 | ||
| The functions of animal microRNAs | Q27860621 | ||
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| microRNAs: tiny regulators with great potential | Q28214699 | ||
| Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase | Q28215845 | ||
| Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway | Q28236951 | ||
| MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells | Q28251177 | ||
| Inhibition of translational initiation by Let-7 MicroRNA in human cells | Q28265842 | ||
| Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter | Q28281340 | ||
| Evidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components | Q28290874 | ||
| A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
| New human and mouse microRNA genes found by homology search | Q28301238 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes | Q29616620 | ||
| Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation | Q29618303 | ||
| The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis | Q29618429 | ||
| MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure | Q29619548 | ||
| Human microRNA (miR29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. | Q30351534 | ||
| MicroRNA and 3T3-L1 pre-adipocyte differentiation | Q30820724 | ||
| microRNAs join the p53 network--another piece in the tumour-suppression puzzle | Q33344707 | ||
| AGO1 defines a novel locus of Arabidopsis controlling leaf development. | Q33368444 | ||
| Lipotoxic diseases | Q34111950 | ||
| Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. | Q34302040 | ||
| Dicing and slicing: the core machinery of the RNA interference pathway | Q34458132 | ||
| Molecular processes during fat cell development revealed by gene expression profiling and functional annotation | Q34481070 | ||
| How do microRNAs regulate gene expression? | Q34573729 | ||
| The microRNA world: small is mighty | Q35559723 | ||
| Nonalcoholic fatty liver disease and the metabolic syndrome | Q36180393 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| Current perspectives in intronic micro RNAs (miRNAs). | Q36287969 | ||
| T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer | Q36403598 | ||
| microRNA-mediated silencing inside P-bodies | Q36688270 | ||
| Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 | ||
| A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice | Q37350730 | ||
| Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice | Q38323956 | ||
| Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway | Q38504286 | ||
| Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression | Q40187900 | ||
| The role of AMP-activated protein kinase in the action of ethanol in the liver | Q40485116 | ||
| Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis | Q43542965 | ||
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
| MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease | Q43818989 | ||
| NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome | Q43875846 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production | Q46427847 | ||
| Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. | Q51793198 | ||
| Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. | Q51958786 | ||
| Preliminary Assessment of the Impact of MicroRNA-Mediated Regulation on Coding Sequence Evolution in Mammals | Q59303881 | ||
| Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice | Q71757386 | ||
| Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients | Q77318114 | ||
| P-bodies take a RISC | Q81927248 | ||
| Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary | Q83365755 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| microRNA | Q310899 | ||
| P304 | page(s) | 1513-23 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism | |
| P478 | volume | 51 |
| Q26801228 | 'Micro-managers' of hepatic lipid metabolism and NAFLD |
| Q34416679 | A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis |
| Q38310305 | A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II. |
| Q38106172 | Advances in the role of microRNAs in lipid metabolism-related anti-atherosclerotic drug discovery |
| Q47175764 | Adverse Intrauterine Environment and Cardiac miRNA Expression. |
| Q34228009 | Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells |
| Q34156501 | Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts. |
| Q36980260 | Analysis of miRNAs and their target genes associated with lipid metabolism in duck liver |
| Q41172771 | Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease |
| Q33616737 | Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol? |
| Q58757771 | Association of MiRNA122 & ADAM17 with Lipids among Hypertensives in Nigeria |
| Q94526362 | Bayesian network analysis of plasma microRNA sequencing data in patients with venous thrombosis |
| Q28550972 | Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway |
| Q38999205 | Biological roles of microRNAs in the control of insulin secretion and action |
| Q92999601 | Bta-miR-124a Affects Lipid Metabolism by Regulating PECR Gene |
| Q42108839 | Caloric restriction-mediated induction of lipid metabolism gene expression in liver is enhanced by Keap1-knockdown |
| Q89935777 | Cholesterol metabolism regulation mediated by SREBP-2, LXRα and miR-33a in rainbow trout (Oncorhynchus mykiss) both in vivo and in vitro |
| Q92404808 | Circular RNA circ_0003204 inhibits proliferation, migration and tube formation of endothelial cell in atherosclerosis via miR-370-3p/TGFβR2/phosph-SMAD3 axis |
| Q26746000 | Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers |
| Q38066239 | Circulating miRNA profiling to identify biomarkers of dysmetabolism. |
| Q52562931 | Circulating microRNAs as Novel Biomarkers for Atherosclerosis. |
| Q39644781 | Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice |
| Q55385529 | Comparative transcriptome analysis to investigate the potential role of miRNAs in milk protein/fat quality. |
| Q36754775 | Complexity of microRNA function and the role of isomiRs in lipid homeostasis. |
| Q37593879 | Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. |
| Q41773152 | Controlling SIRT1 expression by microRNAs in health and metabolic disease |
| Q51739362 | Critical role of miR-125b in lipogenesis by targeting stearoyl-CoA desaturase-1 (SCD-1). |
| Q53752831 | Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. |
| Q35930858 | Deep Sequencing and Screening of Differentially Expressed MicroRNAs Related to Milk Fat Metabolism in Bovine Primary Mammary Epithelial Cells. |
| Q35049249 | Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs |
| Q57818910 | Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity |
| Q35108883 | Discovery of novel and differentially expressed microRNAs between fetal and adult backfat in cattle |
| Q38099737 | Dual role of microRNAs in NAFLD. |
| Q34173988 | Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers |
| Q84582776 | Emerging role of microRNAs in the regulation of lipid metabolism |
| Q26739018 | Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis |
| Q34238886 | Epigenetic regulation of cholesterol homeostasis. |
| Q38272645 | Epigenetic reprogramming in atherosclerosis. |
| Q28073039 | Epigenetics and Cellular Metabolism |
| Q36517990 | Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells |
| Q59801792 | Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity |
| Q53100062 | Expression profiles of miRNAs from bovine mammary glands in response to Streptococcus agalactiae-induced mastitis. |
| Q26747750 | Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer |
| Q50864371 | Fisetin protects against hepatosteatosis in mice by inhibiting miR-378. |
| Q33914388 | Genomic features and computational identification of human microRNAs under long-range developmental regulation |
| Q35186665 | Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. |
| Q90213860 | Integrated mRNA and miRNA profile expression in livers of Jinhua and Landrace pigs |
| Q89495580 | Integrated microRNA and proteome analysis reveal a regulatory module in hepatic lipid metabolism disorders in mice with subclinical hypothyroidism |
| Q34047312 | Interplay of mitochondrial metabolism and microRNAs. |
| Q36320944 | Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice |
| Q38308411 | Lipid metabolism, apoptosis and cancer therapy |
| Q37655272 | Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet |
| Q98465863 | Lipolysis by downregulating miR-92a activates the Wnt/β-catenin signaling pathway in hypoxic rats |
| Q38813514 | Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? |
| Q92247818 | Long-term dietary resveratrol supplementation decreased serum lipids levels, improved intramuscular fat content, and changed the expression of several lipid metabolism-related miRNAs and genes in growing-finishing pigs1 |
| Q58805816 | Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes |
| Q48313374 | Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet. |
| Q37393027 | Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. |
| Q50675151 | Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring. |
| Q36912465 | Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. |
| Q51127575 | MiR-144 affects fatty acid composition by regulating ELOVL6 expression in duck hepatocytes. |
| Q38324718 | MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. |
| Q38808277 | MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia |
| Q37930489 | MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases. |
| Q36167322 | MicroRNA Regulation of Cholesterol Metabolism |
| Q37669025 | MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma |
| Q38011295 | MicroRNA regulation of lipid metabolism |
| Q47998188 | MicroRNA-101-2-5p targets the ApoB gene in the liver of chicken (Gallus Gallus). |
| Q35901547 | MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation |
| Q36075377 | MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis |
| Q38909043 | MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened |
| Q45833730 | MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression |
| Q28547296 | MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D |
| Q37593859 | MicroRNAs and Cardiovascular Disease |
| Q36599274 | MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders |
| Q34321706 | MicroRNAs and lipoproteins: a connection beyond atherosclerosis? |
| Q34717904 | MicroRNAs and liver disease. |
| Q61799870 | MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease |
| Q26796668 | MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics |
| Q35096642 | MicroRNAs in bovine adipogenesis: genomic context, expression and function |
| Q34175509 | MicroRNAs in cardiometabolic disease |
| Q37733659 | MicroRNAs in heart failure: Non-coding regulators of metabolic function |
| Q24633633 | MicroRNAs in lipid metabolism |
| Q33880442 | MicroRNAs in liver disease |
| Q37088373 | MicroRNAs in metabolic disease |
| Q33612997 | MicroRNAs in metabolism and metabolic disorders |
| Q30439971 | MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma |
| Q38150359 | MicroRNAs in the onset and development of cardiovascular disease |
| Q33607587 | MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment |
| Q64087480 | MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease |
| Q38187190 | MicroRNAs: the fine modulators of liver development and function |
| Q96640783 | Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice |
| Q36503853 | Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism |
| Q39280722 | Mitochondrial miRNAs in diabetes: just the tip of the iceberg |
| Q38569945 | Molecular mechanisms of fatty liver in obesity |
| Q39344386 | Nutriepigenomics and malnutrition |
| Q39144695 | Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma |
| Q21245693 | Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease |
| Q27028039 | Post-transcriptional regulation in metabolic diseases |
| Q34305614 | Postprandial regulation of hepatic microRNAs predicted to target the insulin pathway in rainbow trout. |
| Q37148306 | Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis |
| Q37947137 | Regulation of cholesterol homeostasis |
| Q38230799 | Relevance of microRNA in metabolic diseases. |
| Q41873853 | Role of microRNAs in obesity and obesity-related diseases |
| Q36585153 | Roles of microRNA on cancer cell metabolism |
| Q64090010 | Signature MicroRNA expression profile is associated with lipid metabolism in African green monkey |
| Q97537622 | Silencing miR-370-3p rescues funny current and sinus node function in heart failure |
| Q33880588 | Sphingolipids in obesity, type 2 diabetes, and metabolic disease |
| Q39395404 | Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a |
| Q26801471 | The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs |
| Q51769132 | The carnitine system and cancer metabolic plasticity. |
| Q35206661 | The colorectal tumor microenvironment: the next decade |
| Q38714560 | The intersection of nonalcoholic fatty liver disease and obesity |
| Q38749173 | The multifactorial nature of microRNAs in vascular remodelling |
| Q92971753 | The protective effect of bone marrow-derived mesenchymal stem cells in liver ischemia/reperfusion injury via down-regulation of miR-370 |
| Q36728983 | The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. |
| Q39072215 | The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication |
| Q27022700 | Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules |
| Q90043164 | [Correlation between serum microRNA-122 and insulin resistance in obese children] |
| Q37694420 | miR-31 Links Lipid Metabolism and Cell Apoptosis in Bacteria-Challenged Apostichopus japonicus via Targeting CTRP9. |
| Q45826233 | miR-370 is stage-specifically expressed during mouse embryonic development and regulates Dnmt3a |
| Q39227955 | miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma |
| Q40528642 | miR-370 suppresses HBV gene expression and replication by targeting nuclear factor IA. |
| Q92802274 | miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature |
| Q38061096 | miRNAs, polyphenols, and chronic disease |
| Q24634470 | microRNAs and cholesterol metabolism |
| Q38375953 | microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges |
| Q90380026 | ncRNAs: New Players in Mitochondrial Health and Disease? |
Search more.